A year ago, applications for a cell-cultured foie gras product were dropped off at the United States Food and Drug ...

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

Dear reader, according to recent reports and statistics from the Saudi Food and Drug Authority (SFDA), significant and ...

Genting Bhd is poised to benefit from the continued earnings recovery of its key subsidiaries, Genting Malaysia Bhd (GenM) ...

Burns repair house Avita Medical has shored up its balance sheet with a $23 million placement, prompting a 13% share surge.

Taiwan region became the last region across all Everest’s territories to grant full approval for NEFECON (R), together with Mainland China, Singapore, Macao SAR, Hong Kong SAR and South Korea. This ...

Shanghai, China –August 6, 2025 – Everest Medicines (HKEX 1952,“Everest”, or the Company), a biopharmaceutical company focused on the discovery, cl ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate competition in the US artificial heart valve market.

Stock index futures jumped on Tuesday, as the July retail inflation report came largely in line, but core CPI was slightly ...